Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
Though Nell Barber wasn’t sure what her future held after graduating with a bachelor’s degree in psychology, she now uses her interest in human behavior to design systems that leverage machine learning algorithms to identify faces in a crowd.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
How an Alvin M. Weinberg Fellow is increasing security for critical infrastructure components
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
Tackling the climate crisis and achieving an equitable clean energy future are among the biggest challenges of our time.
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
A team of collaborators from ORNL, Google Inc., Snowflake Inc. and Ververica GmbH has tested a computing concept that could help speed up real-time processing of data that stream on mobile and other electronic devices.
Oak Ridge National Laboratory researchers have created a technology that more realistically emulates user activities to improve cyber testbeds and ultimately prevent cyberattacks.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.